Perspectives on Outsourcing

Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Jun 01, 2017
BioPharm International
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
May 01, 2017
BioPharm International
CMOs may be gaining as strategic partners to large bio/pharma companies, but they have a much harder path to navigate.
Apr 01, 2017
BioPharm International
New study shows China biopharma companies face staffing shortages.
Mar 01, 2017
BioPharm International
Moving global manufacturing operations may be more complicated than it appears.
Feb 01, 2017
BioPharm International
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.
Dec 01, 2016
BioPharm International
Biosimilars may be the key to CMO growth.
Nov 01, 2016
BioPharm International
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Oct 01, 2016
BioPharm International
This key bioprocessing segment is expecting continued growth.
Sep 02, 2016
BioPharm International
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
native1_300x100
lorem ipsum